KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amkor Technology (AMKR) Payables (2016 - 2026)

Amkor Technology filings provide 18 years of Payables readings, the most recent being $832.1 million for Q1 2026.

  • On a quarterly basis, Payables rose 36.75% to $832.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $832.1 million, a 36.75% increase, with the full-year FY2025 number at $912.8 million, up 28.04% from a year prior.
  • Payables hit $832.1 million in Q1 2026 for Amkor Technology, down from $912.8 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $927.5 million in Q3 2022 to a low of $608.5 million in Q1 2025.
  • Median Payables over the past 5 years was $760.1 million (2025), compared with a mean of $782.7 million.
  • Biggest five-year swings in Payables: fell 18.37% in 2023 and later soared 36.75% in 2026.
  • Amkor Technology's Payables stood at $899.2 million in 2022, then decreased by 16.09% to $754.5 million in 2023, then fell by 5.51% to $712.9 million in 2024, then increased by 28.04% to $912.8 million in 2025, then decreased by 8.84% to $832.1 million in 2026.
  • The last three reported values for Payables were $832.1 million (Q1 2026), $912.8 million (Q4 2025), and $925.3 million (Q3 2025) per Business Quant data.